Ilexgenin A has been shown to repress melanoma via inducing cell cycle arrest and exerting anti-hepatocellular carcinoma activity by inhibiting the PI3K and STAT3 pathways [220,221]. This evidence concerns the gene STAT3 and hepatocellular carcinoma.